"Radicle has gone from bold idea to industry innovator and indisputable force in the five short years — reimagining what's possible in clinical research," said Radicle Science co-founders Pelin Thorogood and Dr. Jeff Chen. "Landing near the top 20% of the Inc. 5000 in our debut submission, the surge of peer-reviewed, gold-standard publications, the launch of our game-changing Radicle Discovery Gen 2, and the caliber of visionary leaders joining our advisory bench are all proof of the industry's rapid embrace of our disruptive approach. Together, we're accelerating a future where proven, precision wellness is the norm, and accessible to all."
This rapid growth is one key indicator of a broader movement in wellness unlocking novel, actionable insights that will shape the future of evidence-based precision health:
- Advancing diversity and health equity. Spanning all 50 states and engaging 54% women, 25% non-white people of color and 20% rural populations, Radicle's trials reflect the real-world populations wellness products aim to serve.
- Unlocking precision insights that shape the future of health — and business. The size and diversity of Radicle studies and application of AI also deliver unique subpopulation insights that most traditional trials are simply not powered to uncover, fueling both precision health breakthroughs and precision marketing strategies—because when it comes to health, one size does not fit all.
- Earning global recognition. Honors include Nutritional Outlook's Best of the Industry: Service Provider award; the American Herbal Products Association's 2025 Diversity & Inclusion Award; NutraIngredients-USA Start-up of the Year; Fast Company's World Changing Idea; and KPMG Top 10 US Tech Innovator.
Accelerating Leadership in Clinical Research
Since its founding, Radicle Science has conducted blinded, randomized, placebo-controlled trials on >75,000 Americans—more than all U.S. pharmaceutical companies combined in the same period. Further, the company expects by year's end to finish clinical trials on a cumulative of nearly 100 wellness products, illustrating how more companies seek to substantiate the effects of their ingredients and brands in large-scale, gold standard clinical trials. Several recent publications illustrate the power of the Radicle Science approach.
- Maypro — Radicle partnered with Maypro to conduct history's largest randomized, blinded, placebo-controlled trial on Apocynum venetum (Venetron®), demonstrating that Maypro's patented product significantly improved perceived stress and sleep disturbance relative to placebo. This trial was also the first of its kind to rigorously research this asian botanical in a large western population.
(DOI:10.3390/ijtm5020023)
- NutriScience Innovations — Radicle Science partnered with NutriScience Innovations to conduct a large blinded U.S. trial on their patent-pending ButyraGen® for GI health. A modified per–protocol analysis found ButyraGen®, relative to placebo, significantly increased the likelihood of clinically meaningful improvements in belly pain (especially among women), and gas and bloating among women. (DOI:10.3390/nutraceuticals5020014)
- MegaFood — Radicle partnered with MegaFood to conduct history's first and largest randomized, blinded, placebo-controlled trial on a reishi mushroom-containing product (MegaFood Superfood Mushroom Stress Relief)--finding that the product reduced perceived stress in healthy adults in as little as six weeks relative to placebo. (DOI:10.1016/j.cdnut.2025.106183)
The company continues to raise the bar for clinical research on health and wellness products, recently debuting Radicle Discovery Gen 2, which advances its next-generation trials with 100+ clinically validated physical biomarkers, digital biomarkers, wearables integration, AI-powered facial scanning technology for medical-grade vitals, and precision insights to assess the effects of natural products across large, diverse populations in the United States. The result is a tech-enabled, deeply customizable service that delivers faster results, increases the likelihood of meaningful outcomes, and unlocks richer, more actionable insights—standard, not as an "add on."
Enhancing Advisory Bench Strength
Since day 1, Radicle Science has attracted participation and support from leaders across the alternative health, wellness and health tech categories. Today, Dr. Sybille Buchwald-Werner, CEO and founder of Newday; Doug Lynch, CEO and founder of Marketwell Nutrition; and Heather Granato, founder of Nutrachievement; join the strategic advisory board alongside luminaries including Dr. Peter Diamandis, founder and executive chairman of the XPRIZE Foundation, and founder of Singularity University; Joe Dickson, co-founder and head of standards at Merryfield; Pamela Harbour, former commissioner of the Federal Trade Commission (FTC); Dr. Rob Sinnott, former chief scientific officer at USANA; and Tom Aarts, managing director of Nutrition Business Advisors and co-founder of the NBJ Summit. These three new strategic advisors further strengthen the company's reach across the global health and wellness industry.
Dr. Sybille Buchwald-Werner is a serial entrepreneur, global executive, and board member with more than 25 years of leadership in the nutraceutical, pharmaceutical, and health tech sectors. Recognized for translating scientific insights into profitable ventures and advancing consumer health solutions, she leads Newday, a consultancy specializing in business strategy, leadership transformation, and market development—helping companies navigate change, innovate, and thrive. An award-winning leader and board director for Women In Nutraceuticals, she champions diversity, innovation, and science-driven solutions. "I believe AI will become an essential driver of progress across our industry," Buchwald-Werner says. "I'm excited to contribute to Radicle Science's mission of making clinically validated nutraceuticals accessible to more companies and consumers worldwide."
Doug Lynch is an industry award-winning global executive with a three-decade experience in commercialization of medical and functional foods, dietary supplements, cosmetics, animal health, and proprietary actives. His company Marketwell Nutrition Inc. has strategically advised companies on go-to-market strategies, omnichannel sales and marketing, and product differentiation. "I am beyond excited and ridiculously energized to start working closely with the ever-dynamic, ever-enthusiastic, and ever-provocative Pelin Thorogood and Dr. Jeff Chen, along with the entire Radicle Team," Lynch says. "Radicle Science is re-writing the rules by establishing the very best in customer experience, and obtaining meaningful, transformative data in the all-important pursuit of nutritional knowledge, consumer insights, and rigorous claims substantiation."
Heather Granato, founder of strategic consultancy Nutrachievement Inc., brings more than 30 years of experience in the global nutraceutical and food sectors, serving in senior leadership positions with global brands including SupplySide and Vitafoods. A polished international multimedia publishing expert, she is the co-founder and president of Women In Nutraceuticals (WIN), and sits on the board of directors for the Organic & Natural Health Association. Granato says: "Radicle's approach to increasing accessibility and diversity of clinical research, enabling more companies to study the efficacy of their ingredients and products, while also thinking how to develop products for targeted populations using precision insights and technology, resonated deeply with me, and I'm delighted to help spread the story."
About Radicle Science
Radicle Science is a health tech trailblazer on a mission to bring clinical evidence to natural products and wellness. Its pioneering proof-as-a-service platform combines AI, clinical trials, data, and crowdsourcing to rigorously validate the effects of natural products across diverse populations—at unprecedented scale and speed. It delivers improved health outcomes for consumers, innovative R&D insights for brands, and bridges the long-standing gap between consumer belief and scientific validation. Radicle Science has received numerous accolades, including Fast Company's "World Changing Idea" and Nutritional Outlook's Best of Industry "Service Provider." Since its launch in 2021, Radicle Science has conducted placebo-controlled trials on wellness products in over 75,000 Americans—more than the total enrolled in all FDA drug approval trials during the same period. By including populations historically underrepresented in research, the company is advancing health equity and setting a new standard for evidence-based, personalized care. www.radiclescience.com
Media Contact:
Heather Granato
Strategic Marketing Advisor
(480) 390-4327
[email protected]
SOURCE Radicle Science
Share this article